Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Determinants of the Progression and Outcome of Mitral Regurgitation (PROGRAM)

This study is currently recruiting participants. (see Contacts and Locations)
Verified August 2016 by Laval University
Sponsor:
Collaborators:
Canadian Institutes of Health Research (CIHR)
Heart and Stroke Foundation of Canada
University Hospital, Brest
Information provided by (Responsible Party):
Philippe Pibarot, Laval University
ClinicalTrials.gov Identifier:
NCT01835054
First received: April 16, 2013
Last updated: August 31, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2018
  Estimated Primary Completion Date: March 2017 (Final data collection date for primary outcome measure)